| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 32,042 | 34,315 | 34,281 | | Cost of Revenue | 6,984 | 10,733 | 11,136 | | | Gross Profit | 25,058 | 23,582 | 23,145 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 15,159 | 13,859 | 14,856 | | Non Recurring |
-
|
-
|
-
| | Others | 11,921 | (70) | 80 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,022) | 9,793 | 8,209 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,022) | 9,793 | 8,209 | | Interest Expense | 7,445 | 7,754 | 6,702 | | Income Before Tax | (9,467) | 2,039 | 1,507 | | Income Tax Expense | (3,262) | 592 | 487 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,205) | 1,447 | 1,020 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,205) | 1,447 | 1,020 | | Preferred Stock And Other Adjustments | (198) |
-
|
-
| | | Net Income Applicable To Common Shares | ($6,403) | $1,447 | $1,020 |
|
0.22% Nasdaq 
Income Statement
